Myopia, Refractive Development and Eye Growth

Accurate, repeatable measurement of refractive state is fundamental to preclinical myopia research. Subjective refraction, which relies on patient feedback, cannot be used in rodents or birds. Retinoscopy is a valuable reference method, but protocols intended to eliminate accommodation may require cycloplegic drugs such as atropine or cyclopentolate. This can be a relevant confound in studies of muscarinic signaling, accommodation, or pharmacological myopia control. Manual retinoscopy also requires trained operators and is less practical for dense longitudinal measurement schedules.

Eccentric infrared photorefraction resolves these limitations. The technique estimates refractive state from the distribution of infrared light reflected from the retina when the illumination source is offset from the camera axis. The Photorefractor automates this analysis and allows repeated measurements in alert animals without cycloplegia, anesthesia, or specialized retinoscopy training. Multiple measurements per eye can be obtained in rapid succession and averaged, reducing noise from involuntary eye movements, and supporting longitudinal assessment of refractive trajectories during myopia induction, progression, and intervention studies.

Wen et al. (2024, Front Physiol.) provided a particularly important demonstration of the longitudinal resolution achievable with Photorefractor, showing that myopia progression follows a nonlinear pathological trajectory with distinct phases rather than a uniform linear increase. This finding has direct implications for study design: different progression phases may respond differently to the same intervention, and measurements taken only at early or late time points may miss critical transitional dynamics entirely. Jiang et al., (2024, Adv Sci (Weinh).) illustrated the dual- measurement power of combining Photorefractor (refraction) with Keratometer (corneal curvature) in a genetic association context, enabling separate structural and functional phenotype quantification from the same measurement session.

Also see: Myopia.

In axial myopia, posterior scleral remodeling is associated with altered extracellular-matrix composition, reduced biomechanical stiffness, and progressive axial elongation. Scleral fibroblasts, matrix metalloproteinases and their inhibitors, growth-factor signaling, and mechanical loading all contribute to this process. TGF-β-, BMP-, hypoxia-, and metabolism-related pathways have been implicated in experimental models, but their relative roles and the complete molecular cascade remain under investigation.

A central challenge is connecting molecular and tissue-level changes to the whole-eye refractive phenotype. Histology, biochemical assays, and measures such as scleral thickness or collagen organization can identify structural changes, but they do not alone show whether refractive state changed. Repeated photorefraction provides a longitudinal measure of refractive outcome before and after genetic, pharmacological, or environmental manipulation. Ocular biometry should be added when the study aims to attribute a refractive shift specifically to axial elongation rather than corneal or lenticular factors.

Ciliary-muscle function is a related but distinct consideration. The ciliary muscle controls accommodation and therefore can influence lens-related refractive state, particularly in studies involving muscarinic agents. Pharmacological ciliary stress, including pilocarpine exposure, may produce cellular and functional effects that should be evaluated separately from chronic, structurally mediated axial myopia. Refractive measurements can track the optical outcome, while tissue and cellular assays are needed to characterize ciliary-muscle pathology.

For ocular toxicity and systemic-disease paradigms. see also: Ocular & CNS Toxicity Models and Systemic Aging & CNS Decline.

Testing a candidate myopia intervention requires evidence that links a biological target or delivery strategy to a meaningful whole-eye outcome. Molecular and structural measures (such as scleral extracellular-matrix markers, choroidal thickness, MMP activity, or retinal signaling) can support a proposed mechanism, but they do not independently establish whether refractive development has changed.

Repeated refractive measurements with Striatech's Photorefractor enable researchers to track the time course and magnitude of a myopic shift before and after treatment. Interpretation should account for potential corneal and lenticular contributions to refraction, especially in studies involving anterior-segment effects or muscarinic pathways. When a treatment is proposed to slow axial elongation, ocular biometry is needed alongside refractive measurement.

Efficacy studies also need sufficiently frequent longitudinal sampling, appropriate treated-eye, fellow-eye, and untreated controls, and methods compatible with repeated measurement in the same animal. These design features help distinguish a sustained treatment-associated effect from transient optical, accommodative, or handling-related changes.

The central challenge is distinguishing molecular changes that actively alter refractive development from changes that occur secondarily as the eye elongates. This requires controlled perturbation studies that connect a targeted molecular change to whole-eye outcomes, while accounting for the interacting contributions of retinal, choroidal, and scleral tissues.

Examples illustrate the range of mechanisms under investigation. At the post-transcriptional level, m6A RNA modification can regulate RNA stability, translation, and splicing; Zhu et al. (2025, J Transl Med.) examined how inhibition of the retinal m6A demethylase ALKBH5 affected refractive development. At the tissue-remodeling level, Mou et al. (2025, Exp Eye Res.) studied the myopic phenotype and lysosomal/extracellular-matrix changes associated with cathepsin H deficiency, while Wen et al. (2025, Invest Ophthalmol Vis Sci.) investigated Wnt7b/β-catenin/MMP-2 signaling in scleral remodeling during form-deprivation myopia.

Molecular and tissue findings need to be interpreted alongside longitudinal ocular phenotyping. Repeated refractive measurements can show whether a genetic, pharmacological, or environmental perturbation is associated with a change in refractive state over time. Ocular biometry, histology, and molecular assays are then needed to determine whether a refractive change coincides with axial elongation, altered tissue structure, or the proposed biological mechanism.

Oxidative stress, inflammation, mitochondrial dysfunction, and lipid-peroxidation pathways have been implicated in experimental myopia and in complications associated with high myopia. Retinal, retinal pigment epithelial, choroidal, scleral, and ciliary-muscle tissues may each show stress-related molecular changes, but their relative contribution to refractive progression varies by model, tissue, and intervention.

Nutritional compounds and polyphenols are of interest because they can influence antioxidant, inflammatory, metabolic, and cell-survival pathways simultaneously. For example, quercetin (a flavonoid) inhibits multiple pro-oxidative and pro-inflammatory pathways and has been studied in experimental myopia in relation to scleral remodeling and stress-related signaling, while vitamin E and lutein have established antioxidant biology and have been investigated in ocular and ciliary-muscle contexts. Ferroptosis (iron-dependent lipid peroxidation-associated cell death) is another emerging mechanism under investigation in high-myopia-associated ocular pathology.

A central challenge is distinguishing an improvement in molecular stress markers from a sustained effect on refractive development. Longitudinal refractive phenotyping can show whether treatment is associated with attenuation of a myopic shift, while ocular biometry, histology, biochemical assays, and safety assessments are needed to evaluate axial, tissue-level, and mechanistic effects.

Also see: Systemic Aging & CNS Decline and Ocular & CNS Toxicity Models.

High myopia (defined as ≤−6.00 D) is a major cause of irreversible visual impairment in East Asian populations and contributes disproportionately to vision loss from glaucoma, retinal detachment, and myopic maculopathy. The mechanisms linking axial elongation to optic nerve damage are increasingly being investigated. Progressive axial elongation can tilt and deform the optic nerve head and lamina cribrosa, potentially increasing mechanical stress on retinal ganglion cell (RGC) axons at the scleral canal and impairing axoplasmic transport independently of intraocular pressure (IOP). This optic-nerve vulnerability may contribute to the elevated risk of glaucoma, including normal-tension glaucoma, observed in people with high myopia.

Studying these complications in rodent and small-animal models requires functional endpoints in addition to refractive and structural measurements. A Photorefractor measures refractive state but does not assess retinal ganglion cell function, optic-nerve integrity, or visual-pathway performance. Likewise, structural measures such as ocular biometry, OCT, intraocular-pressure measurement, and histology characterize disease-associated anatomy and pathology, but do not by themselves establish the extent of visual impairment.

The OptoDrum measures spatial visual acuity and contrast sensitivity through the optomotor response, providing a noninvasive behavioral measure of visual function in awake animals. This response depends on intact retinal and retinofugal visual pathways, so it can complement structural assessments in models involving retinal ganglion cell degeneration or optic-nerve pathology. However, an optomotor deficit is not specific to a single anatomical site or disease mechanism and should be interpreted alongside refractive, biometric, retinal, and optic-nerve measures.

Disease-associated models of axial elongation can complement conventional form-deprivation and lens-induced paradigms when the research question concerns retinal ganglion cell degeneration, optic-nerve vulnerability, or visual-circuit dysfunction. Their relevance to typical myopia mechanisms should be considered carefully, because axial elongation may result from disease-specific genetic or systemic processes.

Also see: Glaucoma & Optic Nerve Neurodegeneration, Optic Nerve Damage and Rare & Inherited CNS and Eye Disorders.